Translate
Zevra Therapeutics, Inc.
About
10.03USD-0.46 -4.39%
Closed • Updated at 07:46 GMT+00:00Market Cap$592.92M
P/E Ratio4.66
Volume1.36M
Beta0.30
RSI45.02
Gross Margin83.89%
Zevra Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 12 2026
Zevra Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference
May 6 2026
Zevra Reports First Quarter 2026 Financial Results and Corporate Update
Apr 22 2026
Zevra Therapeutics Announces Details for Q1 2026 Financial Results Call
Mar 20 2026
Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
Mar 16 2026
Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million
Recent Videos
ZVRA STOCK : FRESH UPSIDE | ZEVRA THERAPEUTICS STOCK
Apr 14, 2026
Zevra Campus - After Movie de la promotion 0
Apr 12, 2026
How to Invest in Zevra Therapeutics Inc (ZVRA) Step by Step
Apr 04, 2026
The Hidden Biotech Lottery Ticket: What $ZVRA Just Did
Mar 23, 2026
Community Chat
Ask AI
Try asking